Oriol Casanovas
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 18
- Oncology top 1%
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 6
- Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer 17
- PI3K/AKT/mTOR signaling in cancer 7
- Genetics top 2%
- Hepatology top 2%
-
- Neuroendocrine Tumor Research Advances 17
-
- Neuroblastoma Research and Treatments 13
-
- Renal cell carcinoma treatment 7
- Co-authors
- Douglas HanahanGabriele BergersDaniel J. HicklinFrancesc ViñalsMarta Pàez‐RibesElizabeth AllenHiroaki OkuyamaTakaaki Takeda
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Cancer Research (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Oriol Casanovas
69 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 2.1k
- Oncology 2.3k
- Molecular Biology 3.8k
- Genetics 470
- Hepatology 329
Countries citing papers authored by Oriol Casanovas
This map shows the geographic impact of Oriol Casanovas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol Casanovas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol Casanovas more than expected).
Fields of papers citing papers by Oriol Casanovas
This network shows the impact of papers produced by Oriol Casanovas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol Casanovas. The network helps show where Oriol Casanovas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oriol Casanovas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 15 | |
| 2 | 2017 | 28 | |
| 3 | 2016 | 34 | |
| 4 | 2016 | 24 | |
| 5 | 2016 | 10 | |
| 6 | 2015 | 85 | |
| 7 | 2014 | 14 | |
| 8 | 2013 | 56 | |
| 9 | 2013 | 57 | |
| 10 | 2013 | 20 | |
| 11 | 2012 | 149 | |
| 12 | 2012 | 286 | |
| 13 | 2012 | 10 | |
| 14 | 2011 | 62 | |
| 15 | 2010 | 72 | |
| 16 | 2009 | 55 | |
| 17 | Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsbreakdown → | 2005 | 1291 |
| 18 | 2000 | 124 | |
| 19 | 1999 | 53 | |
| 20 | 1997 | 15 |
About Oriol Casanovas
Oriol Casanovas is a scholar working on Cancer Research, Oncology and Neurology, having authored 70 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (18 papers), Angiogenesis and VEGF in Cancer (17 papers), Neuroendocrine Tumor Research Advances (17 papers), Neuroblastoma Research and Treatments (13 papers), Lung Cancer Research Studies (12 papers), Renal cell carcinoma treatment (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (2.3k citations) and Molecular Biology (3.8k citations). Oriol Casanovas has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Douglas Hanahan, Gabriele Bergers, Daniel J. Hicklin, Francesc Viñals, Marta Pàez‐Ribes, Elizabeth Allen, Hiroaki Okuyama, Takaaki Takeda, Masahiro Inoue and Iratxe Zuazo-Gaztelu. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Biological Chemistry, Oncogene and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.